(Q33335346)

English

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sophie D. Fosså

8

object named as

S D Fossa

1 reference

Europe PubMed Central

25 July 2017

author name string

A Horwich

1

1 reference

Europe PubMed Central

25 July 2017

R T Oliver

2

1 reference

Europe PubMed Central

25 July 2017

P M Wilkinson

3

1 reference

Europe PubMed Central

25 July 2017

G M Mead

4

1 reference

Europe PubMed Central

25 July 2017

S J Harland

5

1 reference

Europe PubMed Central

25 July 2017

M H Cullen

6

1 reference

Europe PubMed Central

25 July 2017

J T Roberts

7

1 reference

Europe PubMed Central

25 July 2017

D P Dearnaley

9

1 reference

Europe PubMed Central

25 July 2017

E Lallemand

10

1 reference

Europe PubMed Central

25 July 2017

S P Stenning

11

1 reference

Europe PubMed Central

25 July 2017

MRC Testicular Tumour Working Party

12

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

25 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

25 July 2017

83

1 reference

Europe PubMed Central

25 July 2017

1623-1629

1 reference

Europe PubMed Central

25 July 2017

12

1 reference

Europe PubMed Central

25 July 2017

randomized experiment

0 references

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1498

0 references

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Chemotherapy of disseminated seminoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Simple nontoxic treatment of advanced metastatic seminoma with carboplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Treatment of seminoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Combined management of malignant teratoma of the testis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Combination chemotherapy in germinal cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

21 June 2018

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

31 October 2018

Ambulatory carboplatin monotherapy in advanced seminoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363456

31 October 2018

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced seminoma: the role of chemotherapy and adjunctive surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of chemotherapy in advanced seminoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/11104556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1498

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33335346&oldid=1910652119"